Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 May 2020 | Story Valentino Ndaba | Photo iStock
UFS campuses are transforming into research instruments while simultaneously improving campus operations through the Smart Grid initiative.

Imagine living in a smart home. Imagine monitoring your household’s electricity usage via an integrated system that would notify you of your daily electricity use, peak usage times, and tariffs and consumption at the location of the house. As a user, you would be able to take advantage of such information in order to manage your resources in a more efficient manner. This is just one example of what a Smart Grid can do.

The University of the Free State’s (UFS) Faculty of Natural and Agricultural Sciences has teamed up with the Department of University Estates to drive our very own Smart Grid initiative that is transforming the university’s power network into one with full control and monitoring. “A Smart Grid allows for resource optimisation and asset protection, especially in times like these,” said Nicolaas Esterhuysen, Director of Engineering Services. 

Why is it important for our university to have a Smart Grid?
Dr Jacques Maritz, Lecturer of Engineering Sciences at the Faculty, considers a Smart Grid the natural evolution of power grids in the era of Big Data, IoT and Machine Learning. Resources such as electricity, water and steam can now be monitored and controlled to promote savings and the protection of valuable infrastructure. “Aiming towards Smart Grid status, the UFS will improve resource service-delivery to its staff and students, while sculpting a digital twin of its campus’s power grid, consumer network and resource generators,” he added.
  
How will a Smart Grid improve student success?
The integrity, sustainability and continuous supply of energy directly affects the academic project on all three campuses. The implementation of a Smart Grid could allow improved service delivery and reaction time when any utility is interrupted, as well as maintaining the valuable infrastructure that serves the UFS community.

In what way does a Smart Grid improve the lives of staff members?
According to Dr Maritz  and Esterhuysen: “A Smart Grid will support staff to perform their teaching and research duties in a seamless manner, continuously optimising the energy that they consume to enable full comfort and reliability in energy supply, whilst simultaneously generating savings in energy and preventing wastage.”

The UFS already boasts most of the fundamental building blocks associated with the Smart Grid initiative, especially focusing on monitoring, grid protection, centralised and decentralised solar PV generation and software platforms to serve all these domains. However, to integrate all of these domains into one digital real-time paradigm will be a first for the UFS.

Some examples of the UFS smart grid applications currently in practice
Real-time remote monitoring and control that focuses on the following:
- We are able to detect power outages and don’t have to rely on customer complaints. This enables faster response time and fault identification, thus less downtime and an increase in reliability;
- Solar plant generation; 
- Monitoring our standby generation fleet; 
Identifying usage patterns and saving thereof;
Benchmarking buildings in terms of application usage, area or occupancy to determine energy efficiency and identify savings; and condition-based preventive maintenance that will increase reliability while saving costs.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept